表紙
市場調查報告書

全球多重檢測市場:COVID-19的潛在影響的見解和預測:2020-2024

Global Multiplex Assays (Molecular Multiplexing) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

出版商 Koncept Analytics 商品編碼 948343
出版日期 內容資訊 英文 117 Pages
訂單完成後即時交付
價格
全球多重檢測市場:COVID-19的潛在影響的見解和預測:2020-2024 Global Multiplex Assays (Molecular Multiplexing) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
出版日期: 2020年07月09日內容資訊: 英文 117 Pages
簡介

從2020年到2024年,全球多重分析市場預計將以7.18%的複合年增長率增長,到2024年將達到48.7億美元。市場擴張的驅動力是艾滋病毒感染率上升,新癌症患者病例增加,醫療技術研發支出增加,老年人口增加,醫療費用迅速增加以及藥物開發領域。在日本使用多重免疫測定,在製藥和生物技術行業中廣泛使用伴隨診斷,併購,自身免疫性疾病領域中生物仿製藥的發展,對多點檢驗的需求增加(xPOCT)等因素。

該報告調查了全球多重測定市場,包括新的冠狀病毒感染性疾病(COVID-19)大流行的影響,全球和區域市場分析,市場動態,競爭格局和公司。我們提供公司資料等信息。

內容

第1章概述

  • 簡介
  • 常規分析與多重分析之間的區別
  • 成功進行分子多路復用的因素
  • 多路復用平台
  • 多重分析的未來影像

第2章COVID-19的影響

  • 增加COVID-19檢查
  • 政府增加醫療費用
  • 擴大醫學領域對人工智能的引入
  • 區域影響

第3章世界市場分析

  • 金額基礎的市場
  • 金額基礎的市場預測
  • 產品市場
    • 耗材
    • 設備
    • 軟件
  • 應用市場
    • 研發
    • 臨床診斷市場
    • 伴隨診斷
  • 最終用戶的市場
    • 製藥公司和生物技術公司
    • 研究所
    • 臨床實驗室
    • 醫院
  • 按地區劃分的市場

第4章區域市場分析

  • 北美
  • 亞太地區
  • 歐洲
  • 拉丁美洲
  • 中東/非洲

第5章市場動態

  • 促進增長的因素
    • 艾滋病毒感染率上升
    • 新發癌症患者的病例增加
    • 醫療技術研發費用增加
    • 老年人口增加
    • 醫療費用迅速增加
    • 在藥物發現中廣泛使用多重免疫測定
    • 伴隨診斷程序的廣泛使用
  • 主要趨勢和動向
    • 傳染病發病率增加
    • 增加製藥和生物技術行業的併購
    • 生物仿製藥在自身免疫性疾病領域的發展
    • 對多個即時檢驗(xPOCT)的需求
  • 挑戰
    • 缺乏熟練的專業人員
    • 大型投資資金
    • 各國政府的嚴格規定

第6章競爭情況

  • 世界市場
    • 主要公司的利潤比較
    • 主要公司的研發支出比較
    • 主要公司的市值比較

第7章公司簡介

  • Thermo Fisher Scientific
    • 財務概覽
    • 財務概覽
    • 經營策略
  • Becton,Dickinson and Company(BD)
    • 財務概覽
    • 財務概覽
    • 經營策略
  • BioMerieux
    • 業務概覽
    • 財務概覽
    • 經營策略
  • Bio-Rad Laboratories
    • 業務概覽
    • 財務概覽
    • 經營策略
  • Qiagen
    • 業務概覽
    • 財務概覽
    • 經營策略
  • Luminex Corporation
    • 業務概覽
    • 財務概覽
    • 經營策略
目錄

The global multiplex assays market is expected to reach US$4.87 billion in 2024, increasing at a CAGR of 7.18%, for the duration spanning 2020-2024. The factors such as increasing prevalence of HIV, rising incidences of cancer cases, increasing medical technology R&D spending, growth in geriatric population, upsurge in healthcare expenditures, rise of multiplex immunoassays in drug discovery and escalating adoption of companion diagnostics would drive the growth of the market. However, the market growth would be challenged by dearth of skilled professionals, high investment capital for multiplex assays and stringent government regulations. A few notable trends may include accelerating growth rates of infectious diseases, growth in pharmaceutical and biotech merger & acquisition, monitoring of biosimilar in autoimmune diseases and demand for multiplexed point-of-care tests (xPOCT).

The global multiplex assays market has been segmented into consumables, instruments and software, based on product type. Consumables dominate the market owing to the increase in the number of testing procedures, performed across research institutes, clinical labs and others. Instruments and software have also hold considerable shares in the global market owing to the technological advancement and product innovation, which have eased the entire process of medical research.

The fastest growing regional market is North America, due to the consistent growth in the M&A between the pharmaceutical and biotechnological companies, which have led to the expansion of the research field in the healthcare sector. Further, the sudden outbreak of COVID-19 is causing an adverse disruption in the global population, augmenting the need for precise diagnostic as well as therapeutic option, which is expected to drive the growth of the global multiplex assays market during the forecasted period.

Scope of the report:

The report provides a comprehensive analysis of the global multiplex assays market.

The major regional markets (North America, Asia-Pacific, Europe, Latin America and Middle East & Africa) have been analyzed.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Thermo Fisher Scientific, Becton, Dickson and Company (BD), BioMerieux, Bio-Rad Laboratories, Qiagen and Luminex Corporation) are also presented in detail.

Key Target Audience:

  • Multiplex Assays Kit Manufacturers
  • Medical Technology and Pharmaceutical Firms
  • End Users (pharma & biotech companies, research institutes, clinical labs and hospitals)
  • Investment Banks
  • Healthcare and Medical Consultants
  • Government Bodies & Regulating Authorities

Table of Contents

1. Overview

  • 1.1. Introduction
  • 1.2. Difference Between Traditional Assay and Multiplex Assay
  • 1.3. Determinants of Successful Molecular Multiplexing
  • 1.4. Multiplexing Platforms
  • 1.5. The Future of Multiplex Assays

2. Impact of COVID-19

  • 2.1. Rise in Number of COVID-19 Test
  • 2.2. Growth in Government Spending on Healthcare
  • 2.3. Rise in Adoption of Artificial Intelligence in Healthcare
  • 2.4. Regional Impact

3. Global Market Analysis

  • 3.1. Global Multiplex Assays Market by Value
  • 3.2. Global Multiplex Assays Market Forecast by Value
  • 3.3. Global Multiplex Assays Market by Product
    • 3.3.1. Global Multiplex Assays Consumables Market by Value
    • 3.3.2. Global Multiplex Assays Consumables Market Forecast by Value
    • 3.3.3. Global Multiplex Assays Instruments Market by Value
    • 3.3.4. Global Multiplex Assays Instruments Market Forecast by Value
    • 3.3.5. Global Multiplex Assays Software Market by Value
    • 3.3.6. Global Multiplex Assays Software Market Forecast by Value
  • 3.4. Global Multiplex Assays Market by Application
    • 3.4.1. Global Multiplex Assays Research & Development Market by Value
    • 3.4.2. Global Multiplex Assays Research & Development Market Forecast by Value
    • 3.4.3. Global Multiplex Assays Clinical Diagnostics Market by Value
    • 3.4.4. Global Multiplex Assays Clinical Diagnostics Market Forecast by Value
    • 3.4.5. Global Multiplex Assays Companion Diagnostics Market by Value
    • 3.4.6. Global Multiplex Assays Companion Diagnostics Market Forecast by Value
  • 3.5. Global Multiplex Assays Market by End-Users
    • 3.5.1. Global P&B Companies Multiplex Assays Market by Value
    • 3.5.2. Global P&B Companies Multiplex Assays Market Forecast by Value
    • 3.5.3. Global Research Institutes Multiplex Assays Market by Value
    • 3.5.4. Global Research Institutes Multiplex Assays Market Forecast by Value
    • 3.5.5. Global Clinical Labs Multiplex Assays Market by Value
    • 3.5.6. Global Clinical Labs Multiplex Assays Market Forecast by Value
    • 3.5.7. Global Hospital Multiplex Assays Market by Value
    • 3.5.8. Global Hospital Multiplex Assays Market Forecast by Value
  • 3.6. Global Multiplex Assays Market by Region

4. Regional Market Analysis

  • 4.1. North America
    • 4.1.1. North America Multiplex Assays Market by Value
    • 4.1.2. North America Multiplex Assays Market Forecast by Value
  • 4.2. Asia-Pacific
    • 4.2.1. Asia-Pacific Multiplex Assays Market by Value
    • 4.2.2. Asia-Pacific Multiplex Assays Market Forecast by Value
  • 4.3. Europe
    • 4.3.1. Europe Multiplex Assays Market by Value
    • 4.3.2. Europe Multiplex Assays Market Forecast by Value
  • 4.4. Latin America
    • 4.4.1. Latin America Multiplex Assays Market by Value
    • 4.4.2. Latin America Multiplex Assays Market Forecast by Value
  • 4.5. Middle East & Africa
    • 4.5.1. Middle East & Africa Multiplex Assays Market by Value
    • 4.5.2. Middle East & Africa Multiplex Assays Market Forecast by Value

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Increasing Prevalence of HIV Infections
    • 5.1.2. Rising Incidences of New Cancer Cases
    • 5.1.3. Increasing Medical Technology R&D Spending
    • 5.1.4. Growth in Geriatric Population
    • 5.1.5. Upsurge in Healthcare Expenditures
    • 5.1.6. Rise of Multiplex Immunoassays in Drug Discovery
    • 5.1.7. Escalating Adoption of Companion Diagnostics
  • 5.2. Key Trends and Developments
    • 5.2.1. Accelerating Growth Rates of Infectious Diseases
    • 5.2.2. Growth in Pharmaceutical and Biotech Merger & Acquisition
    • 5.2.3. Monitoring of Biosimilar in Autoimmune Diseases
    • 5.2.4. Demand for Multiplexed Point-of-Care Tests (xPOCT)
  • 5.3. Challenges
    • 5.3.1. Dearth of Skilled Professionals
    • 5.3.2. High Investment Capital for Multiplex Assays
    • 5.3.3. Stringent Government Regulations

6. Competitive Landscape

  • 6.1. Global Market
    • 6.1.1. Key Players - Revenue Comparison
    • 6.1.2. Key Players - R&D Expenditure Comparison
    • 6.1.3. Key Players - Market Capitalization Comparison

7. Company Profiles

  • 7.1. Thermo Fisher Scientific
    • 7.1.1. Financial Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Business Strategies
  • 7.2. Becton, Dickinson and Company (BD)
    • 7.2.1. Financial Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Business Strategies
  • 7.3. BioMerieux
    • 7.3.1. Business Overview
    • 7.3.2. Financial Overview
    • 7.3.3. Business Strategies
  • 7.4. Bio-Rad Laboratories
    • 7.4.1. Business Overview
    • 7.4.2. Financial Overview
    • 7.4.3. Business Strategies
  • 7.5. Qiagen
    • 7.5.1. Business Overview
    • 7.5.2. Financial Overview
    • 7.5.3. Business Strategies
  • 7.6. Luminex Corporation
    • 7.6.1. Business Overview
    • 7.6.2. Financial Overview
    • 7.6.3. Business Strategies

List of figures

  • Difference Between Traditional Assay and Multiplex Assay
  • Factors for the Rising Adoption of Multiplex Assays
  • Global Government Share on Health Spending (2019-2024)
  • Global Healthcare Artificial Intelligence (AI) Market Forecast (2017-2021)
  • Global Multiplex Assays Market by Value (2015-2019)
  • Global Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by Product (2019)
  • Global Multiplex Assays Consumables Market by Value (2015-2019)
  • Global Multiplex Assays Consumables Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Instruments Market by Value (2015-2019)
  • Global Multiplex Assays Instruments Forecast by Value (2020-2024)
  • Global Multiplex Assays Software Market by Value (2015-2019)
  • Global Multiplex Assays Software Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by Application (2019)
  • Global Multiplex Assays Research & Development Market by Value (2015-2019)
  • Global Multiplex Assays Research & Development Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Clinical Diagnostics Market by Value (2015-2019)
  • Global Multiplex Assays Clinical Diagnostics Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Companion Diagnostics Market by Value (2015-2019)
  • Global Multiplex Assays Companion Diagnostics Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by End-Users (2019)
  • Global P&B Companies Multiplex Assays Market by Value (2015-2019)
  • Global P&B Companies Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Research Institutes Multiplex Assays Market by Value (2015-2019)
  • Global Research Institutes Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Clinical Labs Multiplex Assays Market by Value (2015-2019)
  • Global Clinical Labs Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Hospital Multiplex Assays Market by Value (2015-2019)
  • Global Hospital Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by Region (2019)
  • North America Multiplex Assays Market by Value (2015-2019)
  • North America Multiplex Assays Market Forecast by Value (2020-2024)
  • Asia-Pacific Multiplex Assays Market by Value (2015-2019)
  • Asia-Pacific Multiplex Assays Market Forecast by Value (2020-2024)
  • Europe Multiplex Assays Market by Value (2015-2019)
  • Europe Multiplex Assays Market Forecast by Value (2020-2024)
  • Latin America Multiplex Assays Market by Value (2015-2019)
  • Latin America Multiplex Assays Market Forecast by Value (2020-2024)
  • Middle East & Africa Multiplex Assays Market by Value (2015-2019)
  • Middle East & Africa Multiplex Assays Market Forecast by Value (2020-2024)
  • Global HIV Infected Population (2015-2019)
  • Global New Cases of Top Cancer Types (2019)
  • Global Medical Technology R&D Spending (2015-2019)
  • Global Geriatric Population - Age 65 and Above (2015-2019)
  • Global Healthcare Expenditure Per Capita (2015-2019)
  • Global Pharmaceutical R&D Spending (2015-2019)
  • Global Growth Rate of Infectious Diseases Forecast (2017-2022)
  • Global Pharmaceutical and Biotech M&A (2015-2019)
  • Thermo Fisher Scientific Revenue and Net Income (2015-2019)
  • Thermo Fisher Scientific Revenue by Segments (2019)
  • Thermo Fisher Scientific Revenue by Regions (2019)
  • Becton, Dickinson and Company Revenue and Net Income (2015-2019)
  • Becton, Dickinson and Company Revenue by Segments (2019)
  • Becton, Dickinson and Company Revenue by Regions (2019)
  • BioMerieux Net Sales and Net Income (2015-2019)
  • BioMerieux Net Sales by Product Application (2019)
  • BioMerieux Net Sales by Regions (2019)
  • Bio-Rad Laboratories Net Sales and Net Income (2015-2019)
  • Bio-Rad Laboratories Net Sales by Segments (2019)
  • Bio-Rad Laboratories Net Sales by Regions (2019)
  • Qiagen Net Sales and Net Loss (Income) (2015-2019)
  • Qiagen Net Sales by Product Classes (2019)
  • Qiagen Net Sales by Regions (2019)
  • Luminex Corporation Total Revenue and Net Loss (Income) (2015-2019)
  • Luminex Corporation Total Revenue by Source (2019)
  • Luminex Corporation Total Revenue by Regions (2019)

List of Tables

  • Determinants of Successful Molecular Multiplexing
  • Multiplexing Platforms
  • COVID-19 Test per Million Population
  • Key Players - Revenue Comparison (2019)
  • Key Players - R&D Expenditure Comparison (2019)
  • Key Players - Market Capitalization Comparison (2020)